newsfilter
← Latest News
Bloomberg·

Amgen Bulks Up Cancer Pipeline With $1.9 Billion Five Prime Deal

Amgen Inc. said that it had agreed to buy Five Prime Therapeutics Inc. for $1.9 billion in cash, in a deal that will add new cancer therapies to the pharmaceutical giant’s pipeline.